glp-1 receptor agonists adverse effects Gastrointestinal effect and of agonist GLP-1: Genetic Variants Related to

Meanwhile, the application of GLP-1RAs in non-diabetic diseases has also been launched

Figure was created by the author

Further, in a singlearm clinical trial with the same exposure to semaglutide, there were no significant differences in the development of neoplasms when comparing the semaglutide group to the OAD [97]

43 established that an AMPK-dependent pathway promotes inhibition of lipogenesis by GLP-1 in rats fed a high-fat diet

Stimulation of Insulin Secretion (-cells) When GLP-1 RAs bind to receptors on pancreatic -cells, they activate adenylate cyclase (AC), increasing intracellular cyclic AMP (cAMP)

Thus, creating a void to conduct future studies to examine longer duration treatment to check their prolonged effects (98)